Gilead Sciences competitors

Gilead Sciences's competitors include Shire, Novo Nordisk, Biogen, Celgene Corporation, Amgen and CVS Health Corporation
Add company...
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Shire
Shire is a specialty biopharmaceutical company.
Novo Nordisk
Novo Nordisk is a healthcare company and a world leader in diabetes care.
Biogen
Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.
Celgene Corporation
Celgene Corporation is a biopharmaceutical company.
Amgen
Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.
CVS Health Corporation
CVS Health Corporation provides integrated pharmacy health care services.
Founding Date
Founding Date
1987
Founding Date
1986
Founding Date
1923
Founding Date
1978
Founding Date
1986
Founding Date
1980
Founding Date
1963
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Foster City, US HQ
Fremont, US
Oceanside, US
San Dimas, US
Branford, US
Seattle, US
Locations
Dublin, IE HQ
Buenos Aires, AR
Sydney, AU
Wien, AT
Bruxelles, BE
Chácara Santo Antonio (Zona Sul), BR
Sofia, BG
see more
Locations
Bagsvaerd, DK HQ
Mississauga, CA
Beijing, CN
Mainz, DE
Bangalore, IN
Tokyo, JP
Jersey, JE
see more
Locations
Cambridge, US HQ
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
Thousand Oaks, US HQ
Sydney, AU
North Ryde, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Burnaby, CA
see more
Locations
Woonsocket, US HQ
Jersey, JE
Jacksonville, US
Milwaukee, US
Baltimore, US
Frederick, US
Minneapolis, US
see more
Employees
Employees
9,000
Employees
23,0444% decrease
Employees
42,0761% increase
Employees
7,3001% decrease
Employees
7,4675% increase
Employees
20,8008% increase
Employees
160,0001% increase
Valuation ($)
Valuation ($)
97.9 b
Valuation ($)
46.6 b
Valuation ($)
114.9 b
Valuation ($)
69.6 b
Valuation ($)
61.7 b
Valuation ($)
132.8 b
Valuation ($)
81 b
Facebook likes
Facebook likes
5.4 k
Facebook likes
N/A
Facebook likes
523.1 k
Facebook likes
3.1 k
Facebook likes
6.6 k
Facebook likes
N/A
Facebook likes
2.3 m
Twitter followers
Twitter followers
27 k
Twitter followers
6.2 k
Twitter followers
25.8 k
Twitter followers
19.4 k
Twitter followers
19.1 k
Twitter followers
65.4 k
Twitter followers
36.9 k

Financial

Revenue (est.)
Revenue (est.)
$26.1b (FY, 2017)
Revenue (est.)
$15.2b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
$13b (FY, 2017)
Revenue (est.)
$23b (FY, 2016)
Revenue (est.)
$184.8b (FY, 2017)
Cost of goods
Cost of goods
$4.4b (FY, 2017)
Cost of goods
$4.7b (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$461m (FY, 2017)
Cost of goods
$4.2b (FY, 2016)
Cost of goods
$156.2b (FY, 2017)
Gross profit
Gross profit
$21.7b (FY, 2017)
Gross profit
$10.5b (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$12.5b (FY, 2017)
Gross profit
$18.8b (FY, 2016)
Gross profit
$28.5b (FY, 2017)
Net income
Net income
$4.6b (FY, 2017)
Net income
$4.3b (FY, 2017)
Net income
N/A
Net income
$3.7b (FY, 2016)
Net income
$2.9b (FY, 2017)
Net income
$7.7b (FY, 2016)
Net income
$6.6b (FY, 2017)

Operating

Countries
Countries
30 (FY, 2016)
Countries
100 (FY, 2017)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Phase I Trials Products
Phase I Trials Products
3 (FY, 2016)
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
12 (FY, 2016)
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
6 (FY, 2016)
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
3 (FY, 2016)
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
40 (FY, 2017)
Projects in R&D Pipeline
17 (FY, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Shire
HQ
Dublin, IE
Employees
23,044↓ 4% decrease

Shire is a specialty biopharmaceutical company.

View company
Novo Nordisk
HQ
Bagsvaerd, DK
Employees
42,076↑ 1% increase

Novo Nordisk is a healthcare company and a world leader in diabetes care.

View company
Biogen
HQ
Cambridge, US
Employees
7,300↓ 1% decrease

Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.

View company
Celgene Corporation
HQ
Summit, US
Employees
7,467↑ 5% increase

Celgene Corporation is a biopharmaceutical company.

View company